NCT03610789
A Multicenter, Post-Market Clinical Follow-up Study of Subjects With the REDAPT™ System Monolithic Sleeveless/Sleeved Stem and/or Fully Porous Acetabular Shell With XLPE Liner and/or Modular Shell Components Previously Implanted
Enrolling by Invitation
Not specifiedAges 18+ObservationalSmith & Nephew, Inc.
~220 participants
Updated 2025-01-06 on ClinicalTrials.gov
What's tested:REDAPT
At a glance
Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Revision rate
Measured over 10 years post-op
Conditions
Where it's being run
4 sites across 2 statesCalifornia2
New York2
Study leadership
- Nahomie Prophete · STUDY_CHAIR · Smith & Nephew, Inc.
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
What this trial measures
- Revision rate10 years post-op
REDAPT System Monolithic Sleeveless/Sleeved Stem, Fully Porous Acetabular Shell with XLPE liner and Modular Shell Components (with or without Staple, Slice and Blade Augments) cumulative revision rate for any reason 10 years postoperatively.